In the BioHarmony Drug Report Database
Natamycin
Natacyn (natamycin) is a small molecule pharmaceutical. Natamycin was first approved as Natacyn on 1982-01-01. It is used to treat aspergillosis, bacterial infections, blastomycosis, blepharitis, and candidiasis amongst others in the USA.
Trade Name
|
Natacyn |
|---|---|
Common Name
|
natamycin |
ChEMBL ID
|
CHEMBL1200656 |
Indication
|
aspergillosis, bacterial infections, blastomycosis, blepharitis, candidiasis, coccidioidomycosis, conjunctivitis, cryptococcosis, fungal eye infections, histoplasmosis, keratitis, microsporidiosis, protozoan infections, sporotrichosis, trichomonas vaginitis |
Drug Class
|
Antibiotics (Streptomyces strains) |
Image (chem structure or protein)